跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
dorzolamide + timolol
首页
药物
dorzolamide + timolol
dorzolamide + timolol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pharmaceutical composition for treatment of ocular hypertension
EP 2033649 A1
申请人: JIMENEZ BAYARDO ARTURO
优先权: 2007
EP
US
2 件公开
EYELID TREATMENT
US 2013035338 A1
申请人: TANG GORDON
优先权: 2012
CN
US
2 件公开
Compositions and methods for treating eyes and methods of preparation
US 11395825 B2
申请人: OCULAR SCIENCE INC
优先权: 2020
US
2 件公开
Pharmaceutically Stable Compound Consisting of Timolol, Dorzolamide and Brimonidine
US 2009069345 A1
申请人: TORNERO MONTANO JOSE RUBEN
优先权: 2007
US
Ophthalmic pharmaceutical composition and process for the preparation thereof
EP 2886130 A1
申请人: RAFARM S A
优先权: 2013
EP
MICROPARTICLE FORMULATIONS FOR DELIVERY OF ACTIVE AGENTS
CN 111050754 A
申请人: WOLFCREEK BIOTECH PTE LTD
优先权: 2017
CN
Drug sustained-release animal corneal stroma lens and preparation method thereof
CN 111803437 A
申请人: GUANGZHOU SUN SHING BIOTECH CO LTD
优先权: 2020
CN
Pharmaceutical composition for treating glaucoma and application thereof
CN 120478362 A
申请人: UNIV SHENYANG PHARMACEUTICAL
优先权: 2025
CN
REDUCED DOSING REGIMENS FOR GLAUCOMA TREATMENT
US 20260083746 A1
申请人: HARROW IP LLC
优先权: 2025
US
药物
反馈